Rapid identification of clinical yeast isolates by mass spectrometry

Current Fungal Infection Reports

Volumn 4, Issue 3, 2010, Pages 145-150

  Murray, Patrick R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antifungal susceptibility testing; Clinical microbiology; Fungi identification; MALDI TOF; Mass spectrometry; Matrix assisted laser desorption ionization; Yeast identification

Indexed keywords

ACETIC ACID; CARBOHYDRATE; FORMIC ACID; FUNGUS ANTIGEN; INTERNAL TRANSCRIBED SPACER; MONOPHENOL MONOOXYGENASE; POLITEF; POTASSIUM NITRATE; RIBOSOME DNA; RIBOSOME RNA; RNA 16S; TRIFLUOROACETIC ACID; UREASE;

ACCURACY; AGAR MEDIUM; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ANTIGEN DETECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLASTOSCHIZOMYCES; BROTH DILUTION; CANDIDA; CARBOHYDRATE METABOLISM; CONIDIUM; DNA SEQUENCE; FERMENTATION; FUNGAL COLONIZATION; FUNGAL STRAIN; FUNGUS; FUNGUS HYPHAE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GEOTRICUM; INTERMETHOD COMPARISON; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOULD; MYCELIUM; NONHUMAN; PHENOTYPE; REVIEW; RNA SEQUENCE; SACCHAROMYCES; SEQUENCE ANALYSIS; SPORANGIOSPORE; STRAIN IDENTIFICATION; TRICHOSPORON; YEAST;

EID: 79952106896     PISSN: 19363761     EISSN: 1936377X     Source Type: Journal    
DOI: 10.1007/s12281-010-0019-5     Document Type: Review

References (47)

1. Chen SCA, Marriott D, Playford EG, et al.: Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect 2009, 15:662-669.
2. Barker KS, Rogers PD: Recent insights into the mechanisms of antifungal resistance. Curr Infect Dis Rep 2006, 8:449-456. (Pubitemid 44717981)
3. Hazen KC, Howell SA: Candida, Cryptococcus, and other yeasts of medical importance. In Manual of Clinical Microbiology, edn 9. Edited by Murray PR, Baron EJ, Jorgensen JH, et al. Washington, DC: American Society for Microbiology; 2007:1762-1788.
4. Anhalt JP, Fenselau C: Identification of bacteria using massspectrometry. Anal Chem 1975, 47:219-225.
5. Cain TC, Lubman DM, Weber WJ: Differentiation of bacteria using protein profiles from matrix-assisted laser/desorption ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1994, 8:1026-1030.
6. Claydon MA, Davey SN, Edwards-Jones V, Gordon DB: The rapid identification of intact microorganisms using mass spectrometry. Nat Biotechnol 1996, 14:1584-1586. (Pubitemid 26365554)
7. Holland RD, Wilkes JG, Rafii F, et al.: Rapid identification of intact whole bacteria based on spectral patterns using matrix-assisted laser desorption/ionization with time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1996, 14:911-917.
8. Krishnamurthy T, Ross PL, Rajamani U: Detection of pathogenic and non-pathogenic bacteria by matrix assisted laser desorption/ ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1996, 10:883-888. (Pubitemid 126680193)
9. Li TY, Liu BH, Chen YC: Characterization of Aspergillus spores by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2000, 14:2393-2400.
10. Welham KJ, Domin MA, Johnson K, et al.: Characterization of fungal spores by laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2000, 14:307-310. (Pubitemid 30121463)
11. Amiri-Eliasi B, Fenselau C: Characterization of protein biomarkers desorbed by MALDI from whole fungal cells. Anal Chem 2001, 73:5228-5231. (Pubitemid 33032241)
12. Ahmed FE: Utility of mass spectrometry for proteome analysis: part 1. Conceptual and experimental approaches. Expert Rev Proteomics 2008, 5:841-864.
13. Sauer S, Kliem M: Mass spectrometry tools for the classification and identification of bacteria. Nat Rev Microbiol 2010, 8:74-82. This is an excellent review of mass spectrometry methods for the classification and identification of bacteria and fungi.
14. Bernardo K, Pakulat N, Macht M, et al.: Identification and discrimination of Staphylococcus aureus strains using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2002, 2:747-753. (Pubitemid 34693577)
15. Hathout Y, Demirev PA, Ho YP, et al.: Identification of Bacillus spores by matrix assisted laser desorption ionization mass spectrometry. Appl Environ Microbiol 1999, 65:4313-4319.
16. Ilina EN, Borovskaya AD, Malakhova MM, et al.: Direct bacterial profiling by matrix assisted laser desorption-ionization time-of-flight mass spectrometry for identification of pathogenic Neisseria. J Mol Diagn 2009, 11:75-86.
17. Dieckmann R, Helmuth R, Erhard M, Malorny B: Rapid classification and identification of Salmonellae at the species and subspecies levels by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol 2008, 74:7767-7778.
18. Winkler MA, Uher J, Cepa S: Direct analysis and identification of Helicobacter and Campylobacter species by MALDI-TOF mass spectrometry. Anal Chem 1999, 71:3416-3419.
19. Nagy E, Maier T, Urban E, et al.: Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. Clin Microbiol Infect 2009, 15:796-802.
20. Pitarch A, Abian J, Carrascal M, et al.: Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics 2004, 4:3084-3106. (Pubitemid 39372391)
21. Thomas DP, Viudes A, Monteagudo C, et al.: A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis. Proteomics 2006, 6:6033-6041. (Pubitemid 44851388)
22. Hettick JM, Green BJ, Buskirk AD, et al.: Discrimination of Aspergillus isolates at the species and strain level by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting. Anal Biochem 2008, 380:276-281.
23. Hettick JM, Green BJ, Buskirk AD, et al.: Discrimination of Penicillium isolates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting. Rapid Commun Mass Spectrom 2008, 22:2555-2560.
24. Seyfarth F, Ziemer M, Sayer HG, et al.: The use of ITS DNA sequence analysis and MALDI-TOF mass spectrometry in diagnosing an infection with Fusarium proliferatum. Exp Derm 2008, 17:965-971.
25. Degand N, Carbonnelle E, Dauphin B, et al.: Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol 2008, 46:3361-3367.
26. Marklein G, Josten M, Klanke U, et al.: Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol 2009, 47:2912-2917. This is the first large study demonstrating that MALDI-TOF MS can be used to identify a broad spectrum of clinical isolates of yeast accurately and rapidly.
27. Mellmann A, Cloud J, Maier T, et al.: Evaluation of matrix-assisted laser desorption ionization time-of-flight mass spectrometry in comparison to 16 S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol 2008, 46:1946-1954. (Pubitemid 351831825)
28. Mellmann A, Bimet F, Bizet C, et al.: High interlaboratory reproducibility of matrix-assisted laser desorption ionization time of flight mass spectrometry-based species identification of non-fermenting bacteria. J Clin Microbiol 2009, 47:3732-3734.
29. Seng P, Drancourt M, Gouriet F, et al.: Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 2009, 49:543-551.
30. Parisi D, Magliulo M, Nanni P, et al.: Analysis and classification of bacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and a chemometric approach. Anal Bioanal Chem 2008, 391:2127-2134.
31. van Veen SQ, Claas ECJ, Kuijper EJ: High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol 2010, 48:900-907. This study demonstrated that a broad spectrum of bacteria and yeast could be identified by MS. The inability to identify an organism was associated with the absence of sufficient spectra from reference organisms, so the current limitation of the procedure is development of a comprehensive clinical database.
32. Findeisen P, Sismanidis D, Riedl M, et al.: Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 2005, 51:2409-2411. (Pubitemid 41692601)
33. Qian J, Cutler JE, Cole RB, Cai Y: MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers. Anal Bioanal Chem 2008, 392:439-449. This study is a systematic analysis of the variables that influence the reproducibility of MALDI-TOF MS profiles for the differentiation and subtyping of fungi.
34. Freiwald A, Sauer S: Phylogenetic classification and identification of bacteria by mass spectrometry. Nat Protoc 2009, 4:732-742. This report is a series of step-by-step protocols for sample preparation, cell wall disruption and protein extraction, and MALDI-TOF MS analysis for the identification of organisms.
35. Evason DJ, Claydon MA, Gordon DB: Exploring the limits of bacterial identification by intact cell mass spectrometry. J Am Soc Mass Spectrom 2001, 12:49-54. (Pubitemid 34546645)
36. Schuerenberg M, Luebbert C, Eickhoff H, et al.: Prestructured MALDI-MS sample supports. Anal Chem 2000, 72:3436-3442. (Pubitemid 30614913)
37. Tu T, Gross ML: Miniaturizing sample spots for matrix-assisted laser desorption/ionization mass spectrometry. Trends Anal Chem 2009, 28:833-841.
38. Fenselau C, Demirev PA: Characterization of intact microorganisms by MALDI mass spectrometry. Mass Spectrom Rev 2001, 20:157-171. (Pubitemid 34151741)
39. Ryzhov V, Fenselau C: Characterization of the protein subset desorbed by MALDI from whole bacterial cells. Anal Chem 2001, 73:746-750. (Pubitemid 32174452)
40. Arnold RJ, Karty JA, Ellington AD, et al.: Monitoring the growth of a bacteria culture by MALDI-MS of whole cells. Anal Chem 1999, 71:1990-1996. (Pubitemid 29233162)
41. Saenz AJ, Petersen CE, Valentine NB, et al.: Reproducibility of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for replicate bacterial culture analysis. Rapid Commun Mass Spectrom 1999, 13:1580-1585. (Pubitemid 29365786)
42. Valentine N, Wunschel S, Wunschel D, et al.: Effect of culture conditions on microorganism identifications by matrix-assisted laser desorption ionization mass spectrometry. Appl Env Microbiol 2005, 71:58-64. (Pubitemid 40116250)
43. Wang Z, Russon L, Li L, et al.: Investigation of spectral reproducibility in direct analysis of bacteria proteins by matrix-assisted laser désorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1998, 12:456-464. (Pubitemid 28181286)
44. Hsieh S-Y, Tseng C-L, Lee Y-S, et al.: Highly efficient classification and identification of human pathogenic bacteria by MALDI-TOFMS. Mol Cell Proteomics 2008, 7:448-456. (Pubitemid 351298456)
45. Stevenson LG, Drake SK, Murray PR: Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010, 48:444-447.
46. Rogers PD, Vermitsky JP, Edlind TD, Hilliard GM: Proteomic analysis of experimentally induced azole resistance in Candida glabrata. J Antimicrob Chemother 2006, 58:434-438. (Pubitemid 44294961)
47. Marinach C, Alanio A, Palous M, et al.: MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole. Proteomics 2009, 9:4627-4631. This study is a proof-of-concept demonstration that MALDITOF MS can be used to perform antifungal susceptibility tests with results equivalent to the Clinical Laboratory Standards Institute's reference method.